Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
Clinical trial NCT02630030 · COMPLETED
Trial details
- NCT number
- NCT02630030
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2018-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.